Production (Stage)
International Stem Cell Corporation
ISCO
$0.1667
$0.01258.11%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.00% | 16.64% | 2.38% | 3.25% | -5.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.00% | 16.64% | 2.38% | 3.25% | -5.02% |
| Cost of Revenue | 19.27% | 18.33% | 5.30% | 2.41% | -3.68% |
| Gross Profit | 13.69% | 15.47% | 0.31% | 3.85% | -5.95% |
| SG&A Expenses | -4.35% | -0.55% | 8.97% | 7.24% | 8.76% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.94% | 8.29% | 6.62% | 5.11% | 2.64% |
| Operating Income | 87.54% | 89.74% | -205.06% | -44.36% | -309.22% |
| Income Before Tax | 19.29% | -59.54% | -293.71% | -595.65% | 12.64% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 19.29% | -59.54% | -293.71% | -595.65% | 12.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.29% | -59.54% | -293.71% | -595.65% | 12.64% |
| EBIT | 87.54% | 89.74% | -205.06% | -44.36% | -309.22% |
| EBITDA | 116.44% | 129.42% | -1,815.00% | -103.43% | -9,400.00% |
| EPS Basic | 20.78% | -27.20% | -593.20% | -521.19% | -9.46% |
| Normalized Basic EPS | 74.24% | 73.75% | -116.33% | -29.93% | -172.76% |
| EPS Diluted | 25.82% | -39.85% | -615.65% | -549.15% | -16.89% |
| Normalized Diluted EPS | 74.24% | 73.75% | -116.33% | -29.93% | -172.76% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |